A population-based estimate of the extent of colorectal cancer screening in Ontario

American Journal of Gastroenterology

Volumn 99, Issue 6, 2004, Pages 1141-1144

  Rabeneck, Linda ^a   Paszat, Lawrence F ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARIUM ENEMA; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; POPULATION RESEARCH; PRIORITY JOURNAL; SIGMOIDOSCOPY;

AGE DISTRIBUTION; COLONOSCOPY; COLORECTAL NEOPLASMS; CONFIDENCE INTERVALS; ENDOSCOPES; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; ONTARIO; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK ASSESSMENT; SEX DISTRIBUTION; SIGMOIDOSCOPY; SURVIVAL ANALYSIS;

EID: 3142673743     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.30623.x     Document Type: Article

References (16)

1. National Cancer Institute of Canada. Canadian Cancer Statistics 2004, Toronto, Canada, 2004.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-77.
4. Kronberg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
6. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
7. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med 1995;155:1741-48.
8. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
9. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
10. Solomon MJ, McLeod RS. Screening for colorectal cancer. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994;798-809.
11. Colorectal Cancer Screening: Recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 2001;165:206-8.
12. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analysis of colorectal cancer screening: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104.
13. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.
14. Marshall KG. Population-based fecal occult blood screening for colon cancer: Will the benefits outweigh the harm? (letter). Can Med Assoc J 2000;163:545-6.
15. Breen N, Wagener DK, Brown ML, et al. Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.
16. Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged ≥50 years - United States, 2001. Morb Mortal Wkly Rep 2003;52:193-6.